Clinical Trial Update: BEOVU in the Treatment of Dystrophy-related Macular Neovascular Degeneration [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for BEOVU addressing dystrophy-related macular neovascular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Dystrophy
• Dystrophy-related Macular Neovascular Degeneration
• Retinal Dystrophy

Drugs mentioned

• BEOVU (BROLUCIZUMAB)

Snippet

Sponsor: Benha University | Conditions: Dystrophy, Retinal | Phase 4 | Status: UNKNOWN